Microbot Medical Correlations

MBOT Stock  USD 1.70  0.04  2.41%   
The correlation of Microbot Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Microbot Medical Correlation With Market

Average diversification

The correlation between Microbot Medical and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Microbot Medical and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.

Moving together with Microbot Stock

  0.74VOR Vor BiopharmaPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
GCTKINND
WSTSTAA
WSTINND
RMDBDX
RMDISRG
GCTKWST
  
High negative correlations   
GCTKPOAI
POAIINND
GCTKISRG
WSTPOAI
GCTKBDX
GMVDGCTK

Risk-Adjusted Indicators

There is a big difference between Microbot Stock performing well and Microbot Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Microbot Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SDC  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ISRG  1.51 (0.05) 0.00 (0.11) 0.00 
 2.18 
 14.53 
INND  9.88 (0.53) 0.00 (0.29) 0.00 
 30.00 
 64.00 
POAI  6.96  1.12  0.15  1.21  6.76 
 16.54 
 80.58 
STAA  3.04 (0.38) 0.00 (0.82) 0.00 
 6.86 
 28.45 
BDX  0.87  0.06  0.07  0.12  1.50 
 1.72 
 9.44 
WST  2.04 (0.41) 0.00  1.54  0.00 
 3.56 
 40.71 
RMD  1.39 (0.07) 0.00 (0.20) 0.00 
 2.46 
 11.67 
GCTK  9.21 (3.16) 0.00 (4.65) 0.00 
 19.55 
 77.82 
GMVD  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Microbot Medical Corporate Executives

Elected by the shareholders, the Microbot Medical's board of directors comprises two types of representatives: Microbot Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Microbot. The board's role is to monitor Microbot Medical's management team and ensure that shareholders' interests are well served. Microbot Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Microbot Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
MSc MBACTO IsraelProfile